7-Methoxybenzofuran-4-carboxamides as PDE 4 inhibitors: a potential treatment for asthma

Bioorg Med Chem Lett. 2000 Sep 18;10(18):2137-40. doi: 10.1016/s0960-894x(00)00426-1.

Abstract

The synthesis and pharmacological profile of a novel series of 7-methoxybenzofuran-4-carboxamides is described. Some of these compounds were found to be potent inhibitors of phosphodiesterase type 4 (PDE4).

MeSH terms

  • 3',5'-Cyclic-AMP Phosphodiesterases / antagonists & inhibitors*
  • Administration, Oral
  • Animals
  • Asthma / drug therapy
  • Benzamides / adverse effects
  • Benzamides / chemical synthesis
  • Benzamides / pharmacology
  • Benzofurans / adverse effects
  • Benzofurans / chemical synthesis*
  • Benzofurans / pharmacology*
  • Cyclic Nucleotide Phosphodiesterases, Type 4
  • Eosinophilia / drug therapy
  • Guinea Pigs
  • Inhibitory Concentration 50
  • Phosphodiesterase Inhibitors / adverse effects
  • Phosphodiesterase Inhibitors / chemical synthesis*
  • Phosphodiesterase Inhibitors / pharmacology
  • Pyridines / adverse effects
  • Pyridines / chemical synthesis
  • Pyridines / pharmacology
  • Rolipram / adverse effects
  • Rolipram / analogs & derivatives
  • Rolipram / pharmacology
  • Structure-Activity Relationship
  • Vomiting / chemically induced

Substances

  • Benzamides
  • Benzofurans
  • Phosphodiesterase Inhibitors
  • Pyridines
  • 3',5'-Cyclic-AMP Phosphodiesterases
  • Cyclic Nucleotide Phosphodiesterases, Type 4
  • Rolipram
  • piclamilast